Stryker price target raised to $364 from $336 at Wells Fargo

Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Stryker to $364 from $336 and keeps an Overweight rating on the shares. The firm notes Q4 sales and EPS handily beat expectations and 2024 guidance of 7.5%-9.0% organic sales growth and EPS of $11.70-$12.00 was introduced. The midpoint of the EPS guidance is well above consensus, Wells adds.